These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24329168)

  • 1. A critical analysis of Peru's HIV grant proposals to the Global Fund.
    Cáceres CF; Amaya AB; Sandoval C; Valverde R
    Glob Public Health; 2013; 8(10):1123-37. PubMed ID: 24329168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After the Global Fund: who can sustain the HIV/AIDS response in Peru and how?
    Amaya AB; Caceres CF; Spicer N; Balabanova D
    Glob Public Health; 2014; 9(1-2):176-97. PubMed ID: 24499125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007.
    Cáceres CF; Girón JM; Sandoval C; López R; Valverde R; Pajuelo J; Vásquez P; Rosasco AM; Chirinos A; Silva-Santisteban A
    Glob Public Health; 2010; 5(3):247-65. PubMed ID: 20390630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual and reproductive health in HIV-related proposals supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Lusti-Narasimhan M; Collin C; Mbizvo M
    Bull World Health Organ; 2009 Nov; 87(11):816-23. PubMed ID: 20072766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
    Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.
    Kelley KF; Caudwell E; Xueref S; Ha TH; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4():S250-3. PubMed ID: 22544183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International response to the HIV/AIDS epidemic: planning for success.
    Piot P; Coll Seck AM
    Bull World Health Organ; 2001; 79(12):1106-12. PubMed ID: 11799442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasites and vectors carry no passport: how to fund cross-border and regional efforts to achieve malaria elimination.
    Gueye CS; Teng A; Kinyua K; Wafula F; Gosling R; McCoy D
    Malar J; 2012 Oct; 11():344. PubMed ID: 23057734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.
    Lu C; Michaud CM; Khan K; Murray CJ
    Lancet; 2006 Aug; 368(9534):483-8. PubMed ID: 16890835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It's politics, stupid! A political analysis of the HIV/AIDS Trust Fund in Uganda.
    Birungi C; Colbourn T
    Afr J AIDS Res; 2019 Dec; 18(4):370-381. PubMed ID: 31779573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits to evidence-based health policymaking: policy hurdles to structural HIV prevention in Tanzania.
    Hunsmann M
    Soc Sci Med; 2012 May; 74(10):1477-85. PubMed ID: 22445763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The national response to the HIV/AIDS epidemic in Peru: accomplishments and gaps--a review.
    Cáceres CF; Mendoza W
    J Acquir Immune Defic Syndr; 2009 May; 51 Suppl 1():S60-6. PubMed ID: 19384104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Global Fund's leadership on harm reduction: 2002-2009.
    Atun R; Kazatchkine M
    Int J Drug Policy; 2010 Mar; 21(2):103-6. PubMed ID: 20171865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caribbean: Regional support for HIV/AIDS law and policy reform.
    Patterson D
    Can HIV AIDS Policy Law Rev; 2004 Apr; 9(1):29-31. PubMed ID: 15216817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investing for Impact: The Global Fund Approach to Measurement of AIDS Response.
    Jain S; Zorzi N
    AIDS Behav; 2017 Jul; 21(Suppl 1):91-100. PubMed ID: 27896551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.